Back to search

Article

Should rectal cancer be regarded as a different tumor entity from left-sided colon cancer? A clinical and molecular NGS-based study of 552 cases

2023-05-09

Abstract excerpt

Despite the introduction of new molecular classifications, advanced colorectal cancer (CRC) is treated with chemotherapy supplemented with anti-EGFR and anti-VEGF targeted therapy. In this study, 552 CRC cases with different primary tumor locations (250 left side, 190 rectum, and 112 right side) were retrospectively analyzed by next generation sequencing for mutations in 50 genes. The most frequently mutated genes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2b4d09af-d708-565a-8b60-2ed489fd74bb
DOI
10.21203/rs.3.rs-2880010/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Should rectal cancer be regarded as a different tumor entity from left-sided colon cancer? A clinical and molecular NGS-based study of 552 casesDOI 10.21203/rs.3.rs-2880010/v1
Select a neighboring publication to make it the new centre.